Drug interactions between common illicit drugs and prescription therapies.
about
Marijuana: current concepts(†)Performance of the Tobacco, Alcohol, Prescription Medication, and Other Substance Use (TAPS) Tool for Substance Use Screening in Primary Care PatientsLegalization of recreational and medical marijuana: what we don't know.A Brief Patient Self-administered Substance Use Screening Tool for Primary Care: Two-site Validation Study of the Substance Use Brief Screen (SUBS)Validation of Self-Administered Single-Item Screening Questions (SISQs) for Unhealthy Alcohol and Drug Use in Primary Care Patients.Attitudes of Israeli Rheumatologists to the Use of Medical Cannabis as Therapy for Rheumatic Disorders.The next therapeutic challenge in HIV: polypharmacy.Medical cannabis: Another piece in the mosaic of autoimmunity?Accuracy of the Audio Computer Assisted Self Interview version of the Alcohol, Smoking and Substance Involvement Screening Test (ACASI ASSIST) for identifying unhealthy substance use and substance use disorders in primary care patients.Trends in detection rates of risky marijuana use in Colorado health care settings.Factors associated with substance use in older homeless adults: Results from the HOPE HOME study.Rhabdomyolysis in a Patient Taking Both Oxandrolone for Bodybuilding and Methamphetamine.Drug-drug interactions as a result of co-administering Δ9-THC and CBD with other psychotropic agents.“Party N Play” on the Internet: Subcultural Formation, Craigslist, and Escaping from StigmaDrug Interactions With New Synthetic OpioidsThe adverse health effects and harms related to marijuana use: an overview review
P2860
Q21090461-97F31117-568A-4E36-8D81-7180CBBF715FQ30837457-29789FD9-2593-43FD-A048-EB04E6BC31D6Q33774784-394FB367-77D6-4AD9-8359-AEC57C7BAB8AQ35762993-8FF6F9FF-464F-4C64-A49F-B5C5B4E65C97Q36258417-A50F3165-2CEE-4200-9BBB-E3118D78D2B6Q36821862-8CBA9D43-FD18-4B57-B2BE-0BFBAFDF47E1Q37025385-14D43EF7-970D-41AA-9103-EA928AA16EF3Q39012168-5C11750A-10AE-4B0D-A3F5-DC9AC996C8D7Q40384864-119DF4BD-5EF7-41A9-B721-F4EC67703EBDQ44600222-1B96A9BD-5245-468D-A38B-90D055FACD83Q46786347-CE5CAB96-5999-43BC-937F-047BA90996E3Q47554710-2BA3CC4B-8FBF-4889-AABC-9BDF4D6005AAQ47589227-EA48CB01-8CD7-4418-B5F5-9B97A6DC969AQ57275718-AAAD5371-2DB4-4554-82C1-E8E82F8B73DAQ58573297-50603F9A-B23C-4471-AB30-DB648F2955D4Q58779432-9E3CC5C1-FE59-4276-A509-D05545BE9B82
P2860
Drug interactions between common illicit drugs and prescription therapies.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Drug interactions between common illicit drugs and prescription therapies.
@en
Drug interactions between common illicit drugs and prescription therapies.
@nl
type
label
Drug interactions between common illicit drugs and prescription therapies.
@en
Drug interactions between common illicit drugs and prescription therapies.
@nl
prefLabel
Drug interactions between common illicit drugs and prescription therapies.
@en
Drug interactions between common illicit drugs and prescription therapies.
@nl
P2093
P2860
P1476
Drug interactions between common illicit drugs and prescription therapies.
@en
P2093
Darrell Childress
David Stewart
Wesley T Lindsey
P2860
P304
P356
10.3109/00952990.2011.643997
P577
2012-01-05T00:00:00Z